BAM Logo

Drugs in Oral Fluid Scheme - (DOF)

EPTIS factsheet 142172 | Last revision 2019-12-04 | URL: https://www.eptis.bam.de/pts142172 https://www.eptis.bam.de/pts142172

PT provider
PT provider LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing
Based in United Kingdom
Product groups Hazardous substances
Pharmaceutical products, drugs
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Oral fluid Amfetamine -
Barbiturate -
Benzodiazepine -
Cannabinoid -
Cocaine metabolites -
Methadone or metabolites -
Propoxyphene or metabolites -
6-Monoacetylmorphine -
Buprenorphine or metabolites -
Phencyclidine -
LSD or metabolites -
Opiate -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards ISO 15189: 2003
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043 Please see current application form and scheme description for accredited and non-accredited status of test materials and analytes.

Operation is commissioned / requested by
Fees and frequency
Participation fee Depending on samples taken
Regularly operated Yes (4 rounds per annum)
Year of first operation 2009
Contact details of the PT provider
Provider Contact person
LGC AXIO Proficiency Testing
1 Chamberhall Business Park, Chamberhall Green
BL9 0AP Bury, Greater Manchester
United Kingdom

Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Web: https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597 https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597
Mrs Nicola Armstrong
Phone: +44 (0)161 762 2500
Email: axiopt@lgcgroup.com axiopt@lgcgroup.com
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5